“…This is the first epidemiological study of T. gondii infection in humans on the island of Fernando de Noronha. The seroprevalence of antibodies found in human on this island (50.4%) differs from the prevalence rates found in other insular environments in different regions of the world: Islands of Jeju (ELISA: 13.2%) (Hong et al, 2011) and Gangwha-gun (ELISA: 25.8%) (Yang et al, 2012), both in South Korea, Island of Cebu, in the Philippines (Latex Agglutination Test -LAT: 26.4%) (Ybañez et al, 2019) Island of Sri Lanka (ELISA: 29.9%) (Iddawela et al, 2017), Island of Pulau Pangkor, Malaysia (ELISA: 59.7%) (Ahmad et al, 2014), Island of São Tomé and Príncipe, in West Africa (LAT: 63.1%) (Fan et al, 2012), Island of Granada (ELISA: 57%) (Asthana et al, 2006), and 10 island countries (Modified Agglutination Test -MAT: 39.8%) (Dubey et al, 2016), located in the Caribbean, San Carlos Island, Venezuela (Indirect Haemagglutination Assay-IHA, 49.8%) (Chacín-Bonilla et al, 2003).…”